COMBINATION OF TARGETED RADIONUCLIDE THERAPY AND IMMUNOTHERAPY FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

University Of Wisconsin System, Madison WI

Investigators